All In Biotech

Drug Trial Radar · NCT07370207

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Mar 6, 2026

Primary completion

Dec 31, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
AusperBio Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Jan 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with Nucleos(t)ide Analogue (NAs).

Conditions

  • Hepatitis B, Chronic

Interventions

  • AHB-137Drug

    Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with sustained response post AHB-137 treatmentTime frame: 24 Weeks post AHB-137 treatment

Locations

9 sites in 6 countries. Site status is shown where the registry gives one.

  • St Vincents Hospital Melbourne

    Fitzroy, Victoria, Australia · Recruiting

  • Queen Mary Hospital - PPDS

    Hong Kong, China · Recruiting

  • Japanese Red Cross Musashino Hospital

    Musashino, Tokyo, Japan · Recruiting

  • National Center for Global Health and Medicine

    Shinjuku-Ku, Tokyo, Japan · Recruiting

  • New Zealand Clinical Research

    Grafton, Auckland, New Zealand · Recruiting

  • National University Hospital - Singapore

    Singapore, Singapore · Recruiting

  • Chiayi Christian Hospital

    Chiayi City, Taiwan · Recruiting

  • E-DA Hospital

    Kaohsiung City, Taiwan · Recruiting

  • National Taiwan University Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.